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Overview
Pediatric fractures are common injuries and frequently seen
during the course of normal development. The potential
contribution of metabolic factors such as low serum vitamin
D is receiving increasing attention. Understanding newer,
biologically based criteria for vitamin D deficiency and
insufficiency, as well as strategies for oral supplementation
and interdisciplinary consultation with a pediatric endocri-
nologist, is critical when treating children with fractures.
Learning Objectives
Hospital for Special Surgery professional education activities
are intended to improve knowledge, competence, and perfor-
mance of our learners and to lead to better patient care. the
conclusion of the activity, the participant should be able to:
& explain how to test for serum vitamin D levels and
what thresholds denote vitamin D deficiency, insuffi-
ciency, and normal levels;
& identify how to test for vitamin D deficiency/
insufficiency when clinically warranted in otherwise
healthy children and to conduct appropriate vitamin D
testing with pediatric patients in their practice;
& identify effective strategies for vitamin D supplementation
based on measured serum vitamin D levels and to develop
appropriate treatment plans for their patients including an
oral supplementation strategy and a strategy for collabo-
rating with a pediatric endocrinologist when needed.
Target Audience
This activity is targeted at orthopaedic surgeons, pediatri-
cians, primary care physicians, rheumatologists, specialty
physicians, physician assistants, residents, fellows and med-
ical students.
Accreditation
Hospital for Special Surgery is accredited by the
Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.
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Hospital for Special Surgery designates this Journal-based
CME activity for a maximum of 1.0 AMA PRA Category 1
Credit(s)™. Physicians should claim only the credit commen-
surate with the extent of their participation in the activity.
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Abstract Background: The currently accepted ranges
for “normal” serum vitamin D have recently been chal-
lenged in adults on the basis that healthy bone metabolism
requires higher levels of vitamin D than previously thought.
Purpose: The purpose of this study was to evaluate
whether a new “biologically based” classification based
on 25(OH)vitamin D levels that invoke an endocrine
biomarker response (<20 ng/mL for deficiency and
<32 ng/mL for insufficiency) is more appropriate for chil-
dren with fractures than historical criteria. Methods: Serum
25(OH)vitamin D levels were collected from 58 children with
acute low-energy fractures from an outpatient orthopedic clin-
ic from 2009 to 2012. These vitamin D levels were compared
with a cohort of 103 children with chronic kidney disease
(CKD) from an adjacent clinic, a condition with acknowl-
edged low levels of vitamin D. Then, the prevalence of
vitamin D sufficiency in the fracture cohort was evaluated
and compared using both historical guidelines and newer
biologically based criteria. Results: 25(OH)vitamin D levels
in the fracture cohort did not differ from levels in the CKD
cohort (27.5 vs. 24.6 ng/mL) indicating a similar distribution
of vitamin D levels. This finding was consistent when con-
trolling for significant covariables using linear regression
analyses. In the fracture cohort, there was a discrepancy
between historical and biologically based criteria in 64% of
children.Conclusions: The results of the current study suggest
that fracture patients are more frequently vitamin D deficient
than previously thought. This finding is more readily apparent





Pediatric fractures are common injuries [30] often sustained
during the course of normal development, but the potential
contribution of metabolic factors such as vitamin D insufficien-
cy is receiving increasing attention [1, 5, 6, 8, 10, 12, 13, 16, 17,
22, 26, 36, 37, 39, 42, 45, 46, 50]. Historically, target serum
vitamin D levels have been created using healthy population
averages and standard deviations, and sufficiency thresholds
were set at <11 ng/mL for deficiency, 11–20 ng/mL for insuf-
ficiency, and >20 ng/mLwere considered normal. These thresh-
olds were determined via an extensive systematic review of
contemporary literature in American and Canadian populations
by a task force from the Institute of Medicine (IOM) [3,
27, 41]. However, normal value ranges generated using
this method are prone to error, as differences in sample
demographics and disease prevalence between the
Level of Evidence Prognostic study, level II-1 (retrospective study
with comparison cohort). See the Guidelines for Authors for a com-
plete description of levels of evidence.
This work was performed at Hospital for Special Surgery and New
York Presbyterian Hospital/Weill Cornell Medical Center.
Electronic supplementary material The online version of this article
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population to be studied and the reference population
may be present. This is particularly problematic with a
condition that many consider under-recognized in the general
population, such as vitamin D insufficiency.
Recognition of these limitations has prompted clinicians
and researchers to consider newer evaluations of “normal”
levels of vitamin D. Further, the measurement of serum bio-
markers in adults has led to new knowledge that more vitamin
D is required to suppress bone resorption than previously
thought, shifting the “normal” range to higher values [25].
In vivo studies in adults have shown that 25(OH)vitamin D
levels <30 ng/mL are associated with increased PTH [4]. In
children, vitamin D is more critically involved with bone
mineralization (rather than an osteopenic state), and it is
therefore unclear if these more stringent biologically driven
values for adults (<20 ng/mL, deficiency; 20–32 ng/mL,
insufficiency; >32 ng/mL, normal) are applicable to children
as well [50]. Currently, despite the frequency of fractures in
children [30], there is a paucity of primary scientific literature
that reports vitamin D levels in children with fractures.
Understanding if otherwise healthy children with fractures
have low vitamin D levels could prompt clinicians to screen
for serum 25(OH)vitamin D levels at the first presentation of a
fracture. In doing so, vitamin D supplementation could be
added to the treatment plan in order to correct any abnormal-
ities that would otherwise go unnoticed. While a recent meta-
analysis has not supported the use of isolated vitamin D
supplementation in adults to increase bone mineral density
or reduce fracture risk, these results are not externally valid in
children and adolescents, and preliminary data is needed to
explore any associations between low vitamin D and fracture
risk [47]. We hypothesized that 25(OH)vitamin D levels in
pediatric fracture cohort would be low, and likely, no different
than that of a comparison cohort of children with chronic
kidney disease (CKD) well known to have low levels of
vitamin D. We would also suggest that categorization of
vitamin D sufficiency levels within the fracture cohort by
historical methods are inadequate and should be replaced by
a more stringent, biologically based categorization.
To that end, we designed and report herein an investigation
comparing a cohort of children with nonoperatively managed
low-energy long bone fractures who presented to an urban
orthopedic specialty hospital with a comparison cohort of
children with CKD from an adjacent affiliated academic refer-
ral center. Our primary research aim was to determine if the
25(OH)vitamin D levels in the fracture cohort would be dif-
ferent than that of a comparison cohort of children with CKD
well known to have low levels of vitamin D. Our second aim
was to calculate the rate of re-categorization of vitamin D
sufficiency levels within the fracture cohort from historical
methods to a more stringent, biologically based categorization.
Patients and Methods
The study was approved by the hospital institutional review
boards (IRB) at both involved institutions prior to the investi-
gation and represents a retrospective analysis collected labo-
ratory data. The vitamin D data acquired from the fracture
cohort represents serum laboratory studies collected at the time
of initial evaluation as part of the senior author’s (SMD)
standard of care for children who sustain low-energy fractures.
Inclusion criteria for the fracture cohort were patients seen in
the pediatric (under 18 years old) fracture clinic from
November 2009 (inception of routine 25(OH)vitamin D test-
ing) through June 2012 with nonoperatively managed
extraarticular fractures. Fracture pattern was determined by
plain radiograph at the time of presentation by the senior
author (SMD). Only low-energy fractures were included
(e.g., ground-level falls or falls from less than 5 ft, fractures
sustained during recreation/play, and not including fractures
associated with motor vehicle injury). Exclusion criteria were
any chronic illness other than seasonal allergies, any diagnosis
of endocrine dysfunction, fractures of the small bones of the
hands and feet (e.g., metacarpals, metatarsals, phalanges), and
repeat fractures through a previously fractured site. This
yielded a cohort of 58 otherwise healthy children who
sustained low-energy fractures of the clavicle and long bones
of the extremities. Serum levels of 25(OH)vitamin D and total
serum calcium were collected at the first post-injury visit as
part of the senior author’s routine practice. Additionally, pa-
tient demographic variables including age, gender, body mass
index (BMI), race/ethnicity, and insurance payer status (gov-
ernment vs. private insurance) were recorded as part of stan-
dard office procedure.
Due to ethical and logistical institutional review board and
clinical review panel restrictions regarding serum vitamin D
testing on a control cohort of healthy children, a comparison
cohort of children with CKD was drawn from an existing
database. CKD was selected as a comparison cohort because
of the acknowledged low levels of 25(OH)vitamin D associ-
ated with the condition [9, 19, 32, 34, 48, 51]. Inclusion
criteria for the comparison cohort were patients seen in the
adjacent pediatric nephrology clinic during the same time
period (November 2009 though June 2012) with an active
diagnosis of CKD and receiving their first serum
25(OH)vitamin D test. Subjects were excluded if they were
already receiving vitamin D supplementation. This produced
a comparison cohort of 103 non-supplemented children with a
disease process known to have low levels of serum vitamin D.
Available covariables collected in the institutional database
included age, gender, BMI, race/ethnicity, insurance payer
status (government vs. private insurance), and date of labora-
tory testing. Insurance payer status was included as a potential
confounder of interest because of its known impact on access
to musculoskeletal care for children and adolescents [15, 28,
29, 38, 44]. Because seasonal variation in sunlight exposure
plays a critical role in cyclical vitamin D levels [20, 45], the
distribution of seasonality of serum vitamin D testing was
evaluated carefully for equality between groups using previ-
ously established methods [31, 39]. To that end, month and
day of serum testing was classified based on season
(December to March, winter; June to September, summer;
other months, neither winter nor summer) and treated as a
three-level discrete variable.
Data was collected using Microsoft Excel (Microsoft
Corp., Redmond, WA, USA) and analyzed using SAS
Software version 9.3 (SAS Institute, Inc., Cary, NC, USA).
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When the fracture cohort was compared to the CKD cohort,
differences in serum vitamin D levels were evaluated using an
independent sample t test after confirming data normality. Age,
gender, race/ethnicity, BMI, insurance payer status (e.g., gov-
ernment insurance vs. private insurance), and seasonality of
laboratory testing were all evaluated as potential confounding
variables and controlled in linear regression analyses. All
comparative analyses were two-tailed and used p=0.05 as
the threshold for statistical significance. All available patients
meeting inclusion and exclusion criteria were used; therefore,
an a priori power calculation was not performed [33]. Instead,
a post hoc power calculation was performed using PS version
3.1.2 (Vanderbilt University, Nashville, TN, USA) to deter-
mine the threshold effect size that would be statistically signif-
icant between groups given the distribution of serum vitamin
D levels in the fracture cohort.
In the subsequent evaluation of the fracture cohort in
isolation, each child was classified into one of three catego-
ries (vitamin D deficient, vitamin D insufficient, and nor-
mal) for each of two classification schemata: “historical”
(<11 ng/mL, deficiency; 11–20 ng/mL, insufficiency,
>20 ng/mL, normal) [18, 40] and “biological” (<20 ng/mL,
deficiency; 20–32 ng/mL, insufficiency; >32 ng/mL, normal)
[11], based on previously described standards. Rates of cate-
gory reclassification were recorded and analyzed using
Fisher’s exact test.
Results
No difference in serum vitamin D levels was detected be-
tween the fracture and CKD cohorts (Table 1). The fracture
cohort was comprised of children with a variety of long
bone fractures, with the most common being fractures of the
distal radius (33%) (Table 2). No patient received supple-
mentation with calcium or vitamin D outside of their normal
dietary intake. There were no significant differences be-
tween the fracture and CKD cohorts in patient gender,
BMI, or seasonality of vitamin D testing. There was no
significant difference in vitamin D levels between those
with government-issued insurance and private insurance.
Differences in both age and race/ethnicity were noted be-
tween the fracture and CKD cohorts; the fracture cohort was
younger (mean age 8.7 vs. 14.1, p=0.01) and composed of
more Caucasians (86 vs. 33%, p=0.01). Raw mean vitamin
D levels were not significantly different between cohorts,
with a mean difference of 2.9 ng/mL (27.5 vs. 24.6 ng/mL,
p=0.18). Further linear regression modeling was performed
to control for demographic variables that were noted to be
different between cohorts (age, race/ethnicity), as well as
those that have been shown previously to influence serum
vitamin D levels (BMI [2, 17, 49, 52], seasonality of testing
[20, 39, 45]), and continued to show no difference in serum
vitamin D levels between cohorts (p=0.71). A post hoc
power analysis revealed that the study was powered to
detect a difference in serum vitamin D of 4.5 ng/mL be-
tween groups, with an α=0.05 and power=0.8 [14].
When the vitamin D level for each subject in the fracture
cohort was evaluated with both “historical” and “biological”
criteria, 64% of cases were reclassified, which was statisti-
cally significant (p<0.001; Fisher’s exact test). Eighty-four
percent (49/58) were “normal” using the historical classifi-
cation, while only 34% (20/58) of the same patients
remained “normal” after the application of a biologically
based classification system (Table 3).
Discussion
In this comparative cohort study, we evaluated a cohort of
children with nonoperatively managed low-energy long
bone fractures and compared them with a cohort of children
with chronic kidney disease (CKD). In doing so, the current
study revealed that (1) children with fractures have low
levels of serum vitamin D that were no different from a
comparison cohort of children with CKD (a disease with
known low serum 25(OH)vitamin D levels) with an
Table 1 Serum vitamin D and demographic comparisons between the fracture cohort and the chronic kidney disease (CKD) cohort
Variable Fracture cohort (N=58) CKD cohort (N=103) p value Test
Serum 25(OH)vitamin D (ng/mL) 27.5±9.6 24.6±14.7 0.182 t test
Age (years) 8.7±4.7 14.1±5.2 <0.01* t test
Gender (% male) 57% 52% 0.585 Chi-squared
Race/ethnicity (% Caucasian) 86% 33% <0.01* Chi-squared
Body mass index (kg/m2) 17.7±3.1 18.4±4.7 0.311 t test
Insurance payer status (% without private insurance) 19% 26% 0.299 Chi-squared
CKD chronic kidney disease
*p<0.05
Table 2 Fracture characteristics of 58 children with acute low-energy
long bone fractures
Fracture location Number Percent
Distal radius 19 33
Tibia 7 12
Clavicle 6 10




Ankle (distal fibula, extraarticular) 3 5
Radial neck 2 3
Proximal humerus 2 3
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acceptable amount of type II error; and (2) categoriza-
tion of vitamin D sufficiency levels by historical
methods may be inadequate in children with fractures
as they resulted in a high rate of category reclassifica-
tion when a more stringent (elevated) biologically based
categorization was applied. Using the historical classifi-
cation system in children with fractures would therefore
lead to missed diagnoses of vitamin D insufficiency/
deficiency.
Despite a comparative methodology designed to minimize
bias, the current study has limitations. Due to ethical and
logistical institutional restrictions, we were unable to collect
serum vitamin D data from normal subjects and instead relied
on an existing prospective database of laboratory results from
patients with CKD. This is also a relative strength of the study,
however, as comparison with a condition that is acknowl-
edged to have low levels of 25(OH)vitamin D [9, 19, 32, 34,
48, 51] allowed us to establish that these otherwise healthy
children with fractures are not “normal” with regard to serum
vitamin D levels. Furthermore, the use of this database pro-
vided a comparison cohort and adequate power to detect a
difference of 4.5 ng/mL in serum vitamin D concentration
between the cohorts. Therefore, although we did not detect a
difference in raw vitamin D levels between the fracture and
CKD cohorts, our sample size provided an acceptable amount
of type II error. It is important to also note that this study has
shown that children with fractures have vitamin D levels that
are no different than those of a CKD cohort known to have
low levels of vitamin D; this should not be extrapolated to
infer causative effect of decreased vitamin D on increased
fracture risk. Strengths of this study are its use of prospective-
ly collected data, the largest to date uniform sample of low-
energy fractures in an otherwise healthy cohort of chil-
dren, use of a comparison cohort, and the first report of
vitamin D levels in children from metropolitan New
York. While previous studies on vitamin D levels in
children have been conducted in Boston (42° N) [20],
Maine (44° N) [45], Georgia (33° N) [12], the UK (51°
N) [10], Texas (29° N) [36], and New Mexico (31° N)
[46], there are no reports of vitamin D levels in a pediatric
patient population based in New York City (40° N), nor any
data on a large cohort of children with various long bone
fractures. One study, which recorded vitamin D levels in
pediatric fracture patients, was done on 17 African-
American children with forearm fractures in Washington DC
[43]. However, this was a limited sample of 17 cases and
provided only descriptive statistics without any comparative
analysis.
Table 3 Sixty-four percent of children in the fracture cohort were reclassified to worse categories of 25(OH)vitamin D sufficiency when
biologically based criteria were used, which was statistically significant (p<0.001; Fisher’s exact test)
Gray shading indicates those children who were reclassified when biologically based criteria were implemented. BHistorical Criteria^:
<11 ng/mL, deficiency; 11–20 ng/mL, insufficiency; >20 ng/mL, normal. BBiological Criteria^: <20 ng/mL, deficiency; 20–32 ng/mL,
insufficiency; >32 ng/mL, normal
Table 4 Pediatric Recommended Dietary Allowances (RDA) of calci-





0 to 6 months old 200b 400b
6 to 12 months old 260b 400b
1 to 3 years old 700 600
4 to 8 years old 1000 600
9 to 18 years old 1300 600
Table adapted from data from Ross et al [41].
aRecommended Dietary Allowances (RDA) that meets the needs of
≥97.5% of population
bRepresents Adequate Intake (AI) as RDAs were not established for
infants
Table 5 Author’s preferred treatment algorithm for treating children








<12 5000 Immediate referral
to pediatric
endocrinologist
12–20 5000 3 months
20–32 2000 6 months
Children who do not respond to supplementation are referred to pedi-
atric endocrinology, and the following biomarkers are obtained: Serum
PTH, ionized calcium, bone specific alkaline phosphatase, osteocalcin,
and urine N-telopeptide
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In 2003, the American Academy of Pediatrics (AAP) [18]
endorsed a recommendation made by the Institute of Medicine
(IOM), which defined vitamin D deficiency as a serum vitamin
D level below 11 ng/mL, insufficiency as levels between 11
and 20 ng/mL, and adequate vitamin D as a serum level above
20 ng/mL [27]. When the IOM updated the dietary reference
intakes in 2011 [40], existing laboratory reference values were
not addressed. The IOM [40] and Ross et al. [41] both
highlighted the “urgent research and clinical priority” of reas-
sessment of laboratory ranges for vitamin D. In adults, the
historical level has since been considered too low, based on
in vivo basic science research showing that vitamin D levels
below 30 ng/mL are associated with increased PTH secretion
[4, 11, 16]. This finding has led some to increase vitamin D
insufficiency cutoff values in an effort to create a physiolog-
ically driven target serum concentration. The AAP recognizes
these data on biomarkers (particularly PTH) in adults that
have led to more stringent vitamin D target values; however,
they remain undecided with regard to extrapolation of these
data in children. The results of the current study suggest that
vitamin D sufficiency thresholds in children should be
revisited and reclassified based on this biomarker research.
This is the first study to evaluate vitaminD levels in a sample
of children with acute low-energy fractures and compare them to
a cohort of children with known low levels of vitamin D. The
current study revealed that the serum 25(OH)vitamin D level in
the fracture cohort was comparable to levels seen in a CKD
cohort. This suggests that children with fractures may represent a
population that is placed at a similarly increased risk for low
serum levels of vitamin D, though the current study was not
designed to establish population differences. While the absolute
difference in serum 25(OH)vitamin D levels between cohorts
was minimal (2.9 ng/mL), this small difference may even be an
overestimate of the true difference between children with frac-
tures and children with CKD in this study. Because it is known
that non-Hispanic whites have higher serum concentrations of
vitamin D than Blacks and Hispanics [23, 24, 35] primarily due
to increased cutaneous synthesis of cholecalciferol [7, 21], the
small difference in serum vitamin D concentration noted in the
current study was likely partially driven by differences in
race/ethnicity between the fracture and CKD cohorts. This
remained statistically equivalent when controlling for
race/ethnicity, in addition to age and BMI.
Despite this noted low serum concentration of vitamin D in
the fracture cohort, when classified using historical criteria for
vitamin D sufficiency, 80% of the fracture cohort had “normal”
levels of serum 25(OH)vitamin D. Of this cohort, 64% were
reclassified more appropriately to a lower category after the
application of the newer biologically based criteria. This prelim-
inary evidence indicates that the elevated target values for vita-
min D more recently used in adults (<20 ng/mL for deficiency
and <32 ng/mL for insufficiency) are more appropriate than
historical pediatric standards in the setting of pediatric fractures.
Recommended dietary allowances of calcium and vitamin
D were published in the 2011 report of the IOM and summa-
rized by Ross et al. (Table 4) [41]. In the senior author’s (SMD)
practice, children with extremely low serum 25(OH)vitamin D
(<12 ng/mL) are prescribed 5000 IU of vitamin D3 daily and
referred to a pediatric endocrinologist immediately. Those with
vitamin D insufficiency in the range of 12–20 ng/mL are
treated with 5000 IU of vitamin D3 daily and rechecked in
3 months. Children with insufficiency in the 20–32 ng/mL
range are treated with 2000 IU of vitamin D3 daily and
rechecked in 6 months. If there is no improvement in vitamin
D status at the time of repeat serum studies, serum biomarkers
are obtained (PTH, ionized calcium, bone specific alkaline
phosphatase, osteocalcin, and urine N-telopeptide), and the
child is referred to a pediatric endocrinologist (Table 5).
In conclusion, categorization of 25(OH)vitamin D sufficien-
cy levels by historical methods may be inadequate in children
with fractures, as they resulted in a high rate of category reclas-
sification when a more stringent biologically based categoriza-
tion was applied. Using the historical classification system could
therefore lead to missed diagnoses of vitamin D insufficiency/
deficiency, and in turn, a missed opportunity for treatment with
oral supplementation. Like adults, the use of more stringent,
biologically driven criteria for 25(OH)vitamin D sufficiency
(<20 ng/mL for deficiency and <32 ng/mL for insufficiency)
in children may be warranted. Future research should focus on
determining if these results are generalizable to other pediatric
disease states and on establishing more universal serum vita-
min D screening protocols to optimize bone health in children
with fractures.
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